Recently an association was demonstrated between the single nucleotide polymorphism (SNP), rs1042725, within the HMGA2 locus and height as a consequence of a genome wide association (GWA) study of this trait in adults; this observation was also reported in children aged 7-11 years old.
Height in humans has always been considered highly heritable and has also been correlated with certain disorders, such as cancer (Davey Smith, Hart et al. 2000; Gunnell, Okasha et al. 2001) . Twin and family studies have suggested that may be as much as 90% of variation in human height is due to genetic factors (Preece, 1996; Silventoinen, Kaprio et al. 2000; Silventoinen, Kaprio et al. 2001; Macgregor, Cornes et al. 2006; Perola, Sammalisto et al. 2007 ).
Weedon et al. (Weedon, Lettre et al. 2007 ) reported an analysis of this phenotype in the context of genome-wide data generated using the Affymetrix GeneChip Human Mapping 500 K platform on nearly 5000 individuals of self-reported European ancestry, which included approximately 2000 U.K., individuals from the Wellcome Trust Case Control Consortium (Wellcome Trust Case Control Consortium 2007) and approximately 3,000 Scandinavian participants from the Diabetes Genetics Initiative (Saxena, Voight et al. 2007) .
As a consequence, they observed association to common variation in the mobility group-A2 (HMGA2) oncogene. Follow-up analyses in approximately 19,000 more individuals (both adults and children aged 7 and 11 years old) revealed strong replication of this observation, yielding a P = 4 × 10 −16 when all data was combined.
This gene has already been implicated to play a role in height as rare but severe mutations in HMGA2 are known to impact on body size in both mice and humans (Palmert and Hirschhorn, 2003) . They estimated that the key SNP, rs1042725, explains approximately 0.3% of population variation in height (or about 0.4cm increase in adult height per C allele).
Although these HMGA2 fi ndings are compelling, there are continuing concerns regarding the performance of association studies in complex traits. As such, independent replication efforts are now considered mandatory (Patterson and Cardon, 2005) . With the many errors and biases that can blight any individual study, replication by others can ensure that the original fi ndings are robust and can also provide a more accurate estimate of the likely effect size (Hirschhorn, Lohmueller et al. 2002; Page, George et al. 2003) .
We have an ongoing genome wide association (GWA) study on our pediatric cohort from Philadelphia, which includes heights measured for all participants. However, we are not using the Affymetrix arrays employed by Weedon et al. (Weedon, Lettre et al. 2007 ) but rather the competing Illumina Infi nium™ II HumanHap550 BeadChip technology. rs1042725 is not present on this platform but two strong surrogates for the same variant are included in the design, namely rs8756 and rs7968902 (r 2 to rs1042725 = 0.873 and 0.761 respectively in the CEU HapMap). In this study we demonstrate that these surrogates associate strongly with height, when treated as a quantitative trait, in our pediatric cohort, but only in the same age category of 7-11 years old (as previously reported); however this association is absent in the 2-6 and 12-18 years old age categories.
Materials and Methods

Study subjects
All subjects were consecutively recruited from the Greater Philadelphia area from 2006 to 2007 at the Children's Hospital of Philadelphia. Our study consisted of 2,619 Caucasian children of European descent. All subjects were biologically unrelated and were aged between 2 and 18 years old. The number of individuals in the 2-6, 7-11 and 12-18 years old age groups were 709, 617 and 1,293 respectively , with average heights (in centimeters) of 105.07 ± 12.27, 135.07 ± 12.72 and 162.21 ± 12.09. All subjects were between −3 and +3 standard deviations with respect CDC corrected BMI i.e. outliers were excluded to avoid the consequences of potential measurement error. This study was approved by the Institutional Review Board of the Children's Hospital of Philadelphia.
Genotyping
We performed high throughput genome-wide SNP genotyping using the Illumina Infinium™ II HumanHap550 BeadChip technology (Gunderson, Steemers et al. 2005; Steemers, Chang et al. 2006) in the same manner as our center has reported previously (Hakonarson, Grant et al. 2007 ). The resources available for this project included the Illumina technology platform itself plus nine Tecan pipetting robotic systems, eight scanners, a laboratory information management system (LIMS) and automated allele-calling software. The workfl ow was robotic-based for automatic sample processing and included algorithms for quality control of genotypes. The facility infrastructure had suffi cient computational power and servers for data processing and storing, including a series of computers that were integrated (warehouse setting) to perform continuous datamining of all gathered and generated datasets.
Analysis
SNP rs1042725 was not included on the Illumina 550 K BeadChip. However, we searched the HapMap database, and found that two SNPs, which are present on our 550 K BeadChip, rs8756 and rs7968902 respectively were strong surrogates in the CEU HapMap (r 2 = 0.873 and 0.761 respectively). Therefore, we queried the data with a test for these two SNPs to investigate if they were associated with height (age and sex corrected) in our pediatric cohort in the pre-specifi ed age categories.
By treating height as a quantitative trait, association analysis for each SNP was carried out using linear regression with the SNP included as an independent variable (coded as 0, 1, and 2). Both SNPs were in Hardy-Weinberg equilibrium.
All statistical analyses were carried out using the software package plink (http://pngu.mgh. harvard.edu/∼purcell/plink/index.shtml) (Purcell, Neale et al. 2007 ).
Results
Using quantitative trait analysis, we observed signifi cant association between both rs8756 and rs7968902 (strong surrogates for rs1042725 i.e. r 2 = 0.873 and 0.761 in the CEU HapMap respectively) and height, but only in the previously age category of 7-11 years old (Table 1 ). The minor alleles of rs8756 and rs7968902 respectively were signifi cantly associated with height in the 7-11 years old age group (P = 3.53 × 10 −3 and 2.82 × 10 −4
, respectively). However in the 2-6 and 12-18 years old age groups, no association was observed (Table 1) .
Discussion
From an interim analysis of our ongoing GWA study of height in children, we have investigated, with respect to specifi c age categories, variation in the HMGA2 locus previously reported to be associated with height in both children and adults (Weedon, Lettre et al. 2007 ). Consequently, we have replicated the association of this gene with height by further demonstrating its effect in the childhood form of the phenotype, but only for the previously reported 7-11 years old age category. More specifically, the common non-coding variants, rs8756 and rs7968902 respectively (strong surrogates for the previously reported rs1042725), were shown to associate with height in the 7-11 year olds but not for the age groupings below and above this category.
As the association we observe is indeed of a very similar magnitude to that of the original report (Weedon, Lettre et al. 2007 ), this independent replication confi rms HMGA2 as a genuine childhood height gene and further refi nes where the association is most strongest with respect to age. The age categories were selected based on a mixture of what had been previously described and what represented suffi ciently powered cohorts. As Weedon et al. (Weedon, Lettre et al. 2007 ) had focused on the 7-11 age group, we defi ned our grouping around this previous defi nition, such that we grouped all children in this age category and then separately grouped those children that were either older or younger than this category; as such, we had similar numbers in each of the age categories. Note that we did not analyze each distinct age in turn as we were insufficiently powered to do so.
The association may be clouded by extreme growth during early development and then later in puberty and may explain why we do not observe association in the 2-6 and 12-18 years old age categories. Another possible explanation is that age and sex correction is insuffi cient and that other, yet to be determined, co-factors would need to be incorporated in to the model.
Our results lend further support for the role of the HMGA2 gene in height determination. The variants that we observe association to may directly dictate splicing or some other regulatory Table 1 . Quantitative analysis of height results for the minor alleles of the HMGA2 markers strongly associated with Weedon et al. (Weedon, Lettre et al. 2007) NMISS, number of individuals tested; BETA, regression coeffi cient for the test SNP; SE, standard error of the regression coeffi cient; R2, r2 value in linear regression; T, test statistic; P, P-value (additive model).
mechanism, but more likely are in linkage disequilibrium with the causative variant(s). Once our GWA study is complete, we will have the opportunity to look for other variants in the genome that are associated with height in children, as a consequence of our use of a high resolution BeadChip. In addition, we will explore the HMGA2 gene further to elucidate other potential variants that may contribute to height determination in our cohort and to investigate the infl uence by each specifi c age rather than the categories employed in this current study.
